Better GLP-1 Biotech Stock: Altimmune vs. Viking Therapeutics [Yahoo! Finance]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Yahoo! Finance
Lilly and develop GLP-1-targeted medicines for obesity like Wegovy and Zepbound. Both companies have a plausible pathway to continue making their investors wealthier, perhaps by quite a bit. But which one is a better stock to buy right now? Join me in analyzing each, and we'll figure it out together. The case in favor of Viking Therapeutics Of the two companies, Viking Therapeutics is slightly closer to reaching the market. Its lead candidate, VK2735, has already reported some great data from its phase 2b clinical trial, and there might be more on the way. Long story short, the data suggest that its molecule could lead to significantly faster weight loss than the medicines currently being sold by Eli Lilly as well as Novo Nordisk, and with a comparable side effect profile. Study participants lost, on a placebo-adjusted basis, an average of 13.1% of their weight after just 13 weeks of treatment. Additionally, there does not appear to be a plateau effect after which continuing
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Viking Therapeutics, Inc. (VKTX) Sees a More Significant Dip Than Broader Market: Some Facts to Know [Yahoo! Finance]Yahoo! Finance
- Several Factors Negatively Impacted Viking Therapeutics (VKTX) in Q2 [Yahoo! Finance]Yahoo! Finance
- Viking Surges 342% in the Past Year: How Should You Play the Stock? [Yahoo! Finance]Yahoo! Finance
- The Best Biotech Stock to Invest $1,000 in Right Now [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics: GLP-1/GIP Receptor Agonist And Its Competitive Landscape [Seeking Alpha]Seeking Alpha
VKTX
Earnings
- 7/24/24 - Beat
VKTX
Sec Filings
- 8/22/24 - Form 4
- 8/22/24 - Form 4
- 8/21/24 - Form 144
- VKTX's page on the SEC website